ImmunityBio (IBRX) Operating Margin (QoQ) (2014 - 2026)

ImmunityBio (IBRX) Operating Margin (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 ImmunityBio 7.60 Bn 7.22 Bn 43.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1,107.00
Dec 31, 2025 456.00
Sep 30, 2025 9,625.00
Jun 30, 2025 12,031.00
Mar 31, 2025 52,888.00
Dec 31, 2024 39,537.00
Sep 30, 2024 817,306.00
Jun 30, 2024 22.85 Mn
Mar 31, 2024 -17.66 Mn
Dec 31, 2023 3.63 Mn
Sep 30, 2023 10.99 Mn
Jun 30, 2023 -17.67 Mn
Mar 31, 2023 8.53 Mn
Dec 31, 2022 -3.93 Mn
Sep 30, 2022 15.05 Mn
Jun 30, 2022 45.80 Mn
Mar 31, 2022 -66.52 Mn
Dec 31, 2021 9.91 Mn
Sep 30, 2021 -9.41 Mn
Jun 30, 2021 3.67 Mn